Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2007-05-30 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: NOZAY (91620), Essonne
SELARL PHARMACIE DE NOZAY : revenue, balance sheet and financial ratios
SELARL PHARMACIE DE NOZAY is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in NOZAY (91620),
this company of category PME
shows in 2017 a revenue of 1.7 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DE NOZAY (SIREN 498602200)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
1 744 140 €
1 676 685 €
Net income
-63 430 €
101 532 €
111 016 €
278 887 €
162 521 €
150 013 €
90 012 €
127 765 €
118 589 €
102 551 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
165 959 €
179 648 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
6.8%
6.1%
Revenue and income statement
In 2025, SELARL PHARMACIE DE NOZAY records a net loss of 63 k€. This deficit will reduce equity on the balance sheet.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-63 430 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 242%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 25%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
241.71%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
25.413%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DE NOZAY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
192.574
146.311
110.781
99.073
81.156
327.122
219.412
171.014
179.69
241.71
Financial autonomy
31.136
36.823
43.3
45.958
49.631
21.177
28.532
33.394
31.121
25.413
Repayment capacity
11.158
8.847
None
None
None
None
None
None
None
None
Cash flow / Revenue
6.247%
6.879%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
241.712025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average
In 2025, the debt ratio of SELARL PHARMACIE DE NOZAY (241.71) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
25.41%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Watch-6 pts over 3 years
In 2025, the financial autonomy of SELARL PHARMACIE DE NOZAY (25.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 88.70. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
88.705
Liquidity indicators evolution SELARL PHARMACIE DE NOZAY
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
162.704
166.726
177.096
185.231
224.981
277.819
240.116
178.465
109.719
88.705
Interest coverage
25.247
9.529
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
88.72025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Watch-27 pts over 3 years
In 2025, the liquidity ratio of SELARL PHARMACIE DE NOZAY (88.70) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE DE NOZAY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
142 904 €
123 468 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
34
31
0
0
0
0
0
0
0
0
Customer payment term (days)
4
4
0
0
0
0
0
0
0
0
Supplier payment term (days)
33
33
0
0
0
0
0
0
0
0
Positioning of SELARL PHARMACIE DE NOZAY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DE NOZAY with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DE NOZAY
What is the revenue of SELARL PHARMACIE DE NOZAY ?
The revenue of SELARL PHARMACIE DE NOZAY in 2017 is 1.7 M€.
Is SELARL PHARMACIE DE NOZAY profitable?
SELARL PHARMACIE DE NOZAY recorded a net loss in 2025.
Where is the headquarters of SELARL PHARMACIE DE NOZAY ?
The headquarters of SELARL PHARMACIE DE NOZAY is located in NOZAY (91620), in the department Essonne.
Where to find the tax return of SELARL PHARMACIE DE NOZAY ?
The tax return of SELARL PHARMACIE DE NOZAY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DE NOZAY operate?
SELARL PHARMACIE DE NOZAY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart